Market Place
Sourcing Support
All News #Library
Biotech
Rani Therapeutics To Release 2025 Full-Year Financial Results
19 Mar 2026 //
GLOBENEWSWIRE
Rani Pharma Starts Phase 1 Trial Of Ranipill RT-114 For Obesity
08 Jan 2026 //
GLOBENEWSWIRE
Rani to Present Oral Semaglutide Data via RaniPill at ObesityWeek
30 Oct 2025 //
GLOBENEWSWIRE
Rani Therapeutics Reports Q2 2025 Financial Result, Updates
07 Aug 2025 //
GLOBENEWSWIRE
Rani Therapeutics Announces $3.0M Registered Offering Pricing
15 Jul 2025 //
GLOBENEWSWIRE
Rani Therapeutics Shows Bioequivalence of RT-114 to PG-102
26 Mar 2025 //
GLOBENEWSWIRE
Rani Therapeutics to Report Q4 and Full Year 2024 Results
25 Mar 2025 //
GLOBENEWSWIRE
Rani Therapeutics Reveals New Data On GLP-1 Delivery Method
17 Oct 2024 //
GLOBENEWSWIRE
Rani, ProGen Partner To Co-Develop & Commercialize for Obesity
24 Jun 2024 //
CONTRACT PHARMA
Rani Oral Biosimilar Ustekinumab Data At DDW 2024
09 May 2024 //
GLOBENEWSWIRE
Rani Therapeutics expands biologics partnership with Korean firm Celltrion
07 Jun 2023 //
BIOSPECTRUM ASIA
Rani and Celltrion Expand Partnership to Include Adalimumab Biosimilar
05 Jun 2023 //
GLOBENEWSWIRE
Rani Therapeutics Reports 1Q 2023 Financial Results; Provides Corporate Update
10 May 2023 //
GLOBENEWSWIRE
Celltrion signs up to support oral biosimilar of J&J’s Stelara
10 Jan 2023 //
FIERCEPHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.